牛牛AI助理已提取核心訊息
Stuart A Arbuckle, an officer at Vertex Pharmaceuticals Inc, is set to sell 5,034 shares of common stock on 02/26/2024, with an aggregate market value of approximately $2,142,973.80. The shares to be sold were recently acquired on 02/24/2024 as compensation, with half being performance shares and the other half from restricted stock vesting, both sourced from the issuer. Over the past three months, Arbuckle has sold a total of 21,305 shares, generating gross proceeds of $8,778,640.27. The upcoming sale follows a pattern of recent transactions, indicating ongoing trading activity by the officer.
Stuart A Arbuckle, an officer at Vertex Pharmaceuticals Inc, is set to sell 5,034 shares of common stock on 02/26/2024, with an aggregate market value of approximately $2,142,973.80. The shares to be sold were recently acquired on 02/24/2024 as compensation, with half being performance shares and the other half from restricted stock vesting, both sourced from the issuer. Over the past three months, Arbuckle has sold a total of 21,305 shares, generating gross proceeds of $8,778,640.27. The upcoming sale follows a pattern of recent transactions, indicating ongoing trading activity by the officer.
Vertex Pharmicals Inc的高管斯圖爾特·阿巴克爾定於2024年2月26日出售5,034股普通股，總市值約爲2,142,973.80美元。擬出售的股票最近於2024年2月24日作爲補償收購，其中一半是績效股，另一半來自限制性股票歸屬，均來自發行人。在過去的三個月中，Arbuckle共出售了21,305股股票，總收益爲8,778,640.27美元。即將進行的出售遵循了最近的交易模式，表明該官員正在進行交易活動。
Vertex Pharmicals Inc的高管斯圖爾特·阿巴克爾定於2024年2月26日出售5,034股普通股，總市值約爲2,142,973.80美元。擬出售的股票最近於2024年2月24日作爲補償收購，其中一半是績效股，另一半來自限制性股票歸屬，均來自發行人。在過去的三個月中，Arbuckle共出售了21,305股股票，總收益爲8,778,640.27美元。即將進行的出售遵循了最近的交易模式，表明該官員正在進行交易活動。
有用
沒用